Lavipharm S.A. announces, according to the Resolution No. 3/347/12.7.2005 of the Board of Directors of the Capital Market Commission and Article No 14 of Law 3556/2007, that Dr. Athanase Lavidas, son of Telemaque, Chairman and CEO of Lavipharm S.A., has transferred to "T&A Holdings (Luxembourg) S.a.r.l.", a company of his own interests, 1.015.973 common Lavipharm shares, amounting to 1.777.952,7 Euros, on Tuesday, July 8, 2008. Following to the abovementioned transaction, T&A Holdings (Luxembourg) S.a.r.l. voting rights reached 15,27% of Lavipharm SA's total voting rights, i.e. 7.800.054 shares.